瑜珈在大腸急躁症方面的療效研究

Yogic versus conventional treatment in diarrhea-predominant irritable bowel syndrome: a randomized control study.

Taneja I, Deepak KK, Poojary G, Acharya IN, Pandey RM, Sharma MP.

Appl Psychophysiol Biofeedback. 2004 Mar;29(1):19-33.

Department of Physiology, All India Institute of Medical Sciences, New Delhi 110029, India.

This study was conducted to evaluate the comparative effect of yogic and conventional treatment in diarrhea-predominant irritable bowel syndrome (IBS) in a randomized control design. The patients were 22 males, aged 20-50 years, with confirmed diagnosis of diarrhea-predominant IBS. The conventional group (n = 12, 1 dropout) was given symptomatic treatment with loperamide 2-6 mg/day for 2 months, and the yogic intervention group (n = 9) consisted of a set of 12 asanas (yogic poses, i.e., Vajrasana, Shashankasana, Ushtrasana, Marjariasana, Padhastasana, Dhanurasana, Trikonasana in two variations, Pawanmuktasana, and Paschimottanasana) along with Surya Nadi pranayama (right-nostril breathing) two times a day for 2 months. All participants were tested at three regular intervals, at the start of study--0 month, 1 month, and 2 months of receiving the intervention--and were investigated for bowel symptoms, autonomic symptoms, autonomic reactivity (battery of five standard tests), surface electrogastrography, anxiety profile by Spielberger's Self Evaluation Questionnaire, which evaluated trait and state anxiety. Two months of both conventional and yogic intervention showed a significant decrease of bowel symptoms and state anxiety. This was accompanied by an increase in electrophysiologically recorded gastric activity in the conventional intervention group and enhanced parasympathetic reactivity, as measured by heart rate parameters, in yogic intervention group. The study indicates a beneficial effect of yogic intervention over conventional treatment in diarrhea-predominant IBS.

這項研究被處理評價yogic的比較效應，在隨機化排列裡的在顯著腹瀉的腸過敏綜合症(IBS)裡的道統的治療控制設計。 那些病患是22個男性，20-50 年歲，帶有顯著腹瀉的IBS的證實診斷。 傳統(n = 12，1 退出)組 有loperamide被給對症療法2-6毫克/天2個月， 並且yogic 介入(n = 9)組由一套12 asanas組成(yogic姿勢， 即，在兩個變化量方面的Vajrasana，Shashankasana，Ushtrasana，Marjariasana，Padhastasana，Dhanurasana，Trikonasana，Pawanmuktasana 和Paschimottanasana)， 2個月Surya Nadi pranayama(右鼻孔呼吸)一天兩次。 全部參加者被在3 段有規律的間隔測試，在研究一開始的時候 --0個月，1個月和2個月的收到介入 --並且被為腸症狀調查， autonomic症狀， autonomic reactivity(5 標準考試的電池)，表面electrogastrography，憂慮型以Spielberger的自我評估詢問表，評價特性並且說明憂慮。 兩個顯示一腸症狀的顯著的減少的常規和yogic 介入二月並且說明憂慮。 記錄在傳統的介入組裡的胃活動並且提升parasympathetic reactivity，這伴隨著electrophysiologically的增加， 象以心率參數測量，在yogic 介入組的那樣。 研究表明一種yogic對在顯著腹瀉的IBS裡的傳統的治療的介入的有利的效應。